REQUEST A DEMO
Total
USD $0.00
Search more companies

Drug Pharmaceutical S A S (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Lessors of Real Estate
Full name: Drug Pharmaceutical S A S Profile Updated: January 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Drug Pharmaceutical S A S is an enterprise located in Colombia, with the main office in Bogota D.C.. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on January 18, 2001. In its most recent financial highlights, the company reported a net sales revenue drop of 19.13% in 2025. Its’ total assets recorded a negative growth of 15.32%. The net profit margin of Drug Pharmaceutical S A S decreased by 4.79% in 2025.

Headquarters
Carrera 15 # 88 - 21 Oficina 702
Bogota D.C.; Bogota D.C; Postal Code: 0814

Contact Details: Purchase the Drug Pharmaceutical S A S report to view the information.

Basic Information
Registered Capital:
Purchase the Drug Pharmaceutical S A S report to view the information.
Financial Auditors:
Purchase the Drug Pharmaceutical S A S report to view the information.
Incorporation Date:
January 18, 2001
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Drug Pharmaceutical S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-19.13%
Total Operating Revenue
-19.13%
Operating Profit
-49.15%
Net Profit/Loss for the Period
-55.07%
Total Assets
-15.32%
Total Equity
12.47%
Operating Profit Margin
-3.99%
Net Profit Margin
-4.79%
Return on Equity (ROE)
-16.66%
Quick Ratio
-0.09%
Cash Ratio
0.27%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?